Finally Time To Cut Your Stake? Raymond James Downgrades DaVita (NYSE:DVA) Shares

November 9, 2018 - By Matthew Medley

DaVita Inc. (NYSE:DVA) Logo

Investors sentiment decreased to 0.85 in Q2 2018. Its down 0.05, from 0.9 in 2018Q1. It turned negative, as 42 investors sold DaVita Inc. shares while 156 reduced holdings. 50 funds opened positions while 119 raised stakes. 142.23 million shares or 2.37% less from 145.68 million shares in 2018Q1 were reported.

Tci Wealth Advsr reported 0% of its portfolio in DaVita Inc. (NYSE:DVA). American Intll Gru reported 47,645 shares. Twin Tree Mgmt L P stated it has 0.04% of its portfolio in DaVita Inc. (NYSE:DVA). State Of Alaska Department Of Revenue has 37,631 shares. Moreover, Robeco Institutional Asset Management Bv has 0.04% invested in DaVita Inc. (NYSE:DVA) for 124,956 shares. Moreover, Suntrust Banks Incorporated has 0% invested in DaVita Inc. (NYSE:DVA). 1.51M are owned by Par Mgmt Inc. Public Employees Retirement Sys Of Ohio owns 76,403 shares. Korea Inv reported 19,009 shares. Los Angeles Mngmt & Equity owns 56,388 shares or 0.02% of their US portfolio. Toronto Dominion Bank & Trust holds 91,159 shares or 0.01% of its portfolio. The Minnesota-based Walleye Trading Limited Liability Corp has invested 0.07% in DaVita Inc. (NYSE:DVA). Tiaa Cref Investment Mngmt Ltd Com invested in 0.01% or 233,674 shares. Credit Suisse Ag accumulated 0.01% or 216,294 shares. Neuberger Berman Ltd Co owns 1.32 million shares.

Since May 14, 2018, it had 0 insider purchases, and 3 sales for $211,988 activity. 1,264 shares valued at $86,918 were sold by Arway Pamela M on Thursday, June 7. 1,505 shares were sold by ROPER WILLIAM L, worth $102,677 on Tuesday, May 22.

DaVita (NYSE:DVA) Receives a Downgrade

In a research report revealed on 8 November, research professionals at Raymond James’s equity research division downgraded the rating for DaVita (NYSE:DVA) shares from the previous “Strong Buy” to a “Market Perform”.

DaVita Inc. (NYSE:DVA) Ratings Coverage

Among 2 analysts covering DaVita (NYSE:DVA), 1 have Buy rating, 0 Sell and 1 Hold. Therefore 50% are positive. DaVita had 2 analyst reports since June 6, 2018 according to SRatingsIntel. JP Morgan upgraded the stock to “Neutral” rating in Thursday, September 13 report.

The stock decreased 7.79% or $5.93 during the last trading session, reaching $70.15. About 5.96 million shares traded or 271.91% up from the average. DaVita Inc. (NYSE:DVA) has risen 12.06% since November 9, 2017 and is uptrending. It has underperformed by 3.56% the S&P500.

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease . The company has market cap of $11.71 billion. It operates through two divisions, DaVita Kidney Care and DaVita Medical Group. It has a 23.93 P/E ratio. The firm operates kidney dialysis centers and provides related lab services in outpatient dialysis centers.

More notable recent DaVita Inc. (NYSE:DVA) news were published by: Seekingalpha.com which released: “Fresenius up 9% premarket on California rejection of Prop 8” on November 07, 2018, also Bizjournals.com with their article: “Election Day ballot measures send ripples, potential headaches throughout Corporate America” published on November 07, 2018, Benzinga.com published: “DaVita Q3 Earnings Preview” on November 07, 2018. More interesting news about DaVita Inc. (NYSE:DVA) were released by: Streetinsider.com and their article: “DaVita (DVA) says it’s grateful that Californians voted down Proposition 8” published on November 07, 2018 as well as Benzinga.com‘s news article titled: “65 Stocks Moving In Thursday’s Mid-Day Session” with publication date: November 08, 2018.

DaVita Inc. (NYSE:DVA) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.